ACM
Asymmetry Capital Management Portfolio holdings
AUM
$188M
This Quarter Return
+33.69%
1 Year Return
+45.88%
3 Year Return
+300.28%
5 Year Return
+633.15%
10 Year Return
–
AUM
$66.1M
AUM Growth
+$66.1M
(+47%)
Cap. Flow
+$18.6M
Cap. Flow
% of AUM
28.12%
Top 10 Holdings %
Top 10 Hldgs %
79%
Holding
27
New
5
Increased
9
Reduced
3
Closed
10
Top Buys
| 1 |
PTC Therapeutics
PTCT
|
$7.68M |
| 2 |
ACOR
Acorda Therapeutics, Inc.
ACOR
|
$6.23M |
| 3 |
XNPT
XENOPORT, INC.
XNPT
|
$5.09M |
| 4 |
UnitedHealth
UNH
|
$4.2M |
| 5 |
Quest Diagnostics
DGX
|
$2.34M |
Top Sells
| 1 |
DaVita
DVA
|
$4.07M |
| 2 |
Stryker
SYK
|
$2.61M |
| 3 |
MiMedx Group
MDXG
|
$2.22M |
| 4 |
ENDP
Endo International plc
ENDP
|
$1.84M |
| 5 |
Bristol-Myers Squibb
BMY
|
$1.77M |
Sector Composition
| 1 | Healthcare | 80.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
DaVita
DVA
$9.72B
| – | – |
-56,290
| Closed | -$4.07M |
|
|
27
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-29,900
| Closed | -$1.77M |
|